| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| João F C Pedrazzi, Amanda J Sales, Francisco S Guimarães, Sâmia R L Joca, José A S Crippa, Elaine Del Be. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in neuro-psychopharmacology & biological psychiatry. vol 111. 2021-11-11. PMID:34015384. |
cannabidiol (cbd), a major non-psychotomimetic component of the cannabis sativa plant, shows therapeutic potential in several psychiatric disorders, including schizophrenia. |
2021-11-11 |
2023-08-13 |
mouse |
| Lisa-Marie Greenwood, Samantha J Broyd, Hendrika H van Hell, Juanita Todd, Alison Jones, Robin M Murray, Rodney J Croft, Patricia T Michie, Nadia Solowi. Acute effects of Δ Psychopharmacology. 2021-11-01. PMID:34719731. |
acute effects of Δ mismatch negativity (mmn) is a candidate endophenotype for schizophrenia subserved by n-methyl-d-aspartate receptor (nmdar) function and there is increasing evidence that prolonged cannabis use adversely affects mmn generation. |
2021-11-01 |
2023-08-13 |
human |
| Alejandra Delgado-Sequera, María Hidalgo-Figueroa, Marta Barrera-Conde, Mª Carmen Duran-Ruiz, Carmen Castro, Cristina Fernández-Avilés, Rafael de la Torre, Ismael Sánchez-Gomar, Víctor Pérez, Noelia Geribaldi-Doldán, Patricia Robledo, Esther Berrocos. Olfactory Neuroepithelium Cells from Cannabis Users Display Alterations to the Cytoskeleton and to Markers of Adhesion, Proliferation and Apoptosis. Molecular neurobiology. vol 58. issue 4. 2021-10-27. PMID:33237429. |
our results indicate that cannabis may alter key processes of the developing brain, some of which are similar to those reported in mental disorders like digeorge syndrome, schizophrenia and bipolar disorder. |
2021-10-27 |
2023-08-13 |
human |
| Daniel Guinart, Estefanía Moreno, Liliana Galindo, Aida Cuenca-Royo, Marta Barrera-Conde, Ezequiel J Pérez, Cristina Fernández-Avilés, Christoph U Correll, Enric I Canela, Vicent Casadó, Arnau Cordomi, Leonardo Pardo, Rafael de la Torre, Víctor Pérez, Patricia Robled. Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use. Schizophrenia bulletin. vol 46. issue 6. 2021-10-25. PMID:32249318. |
altered signaling in cb1r-5-ht2ar heteromers in olfactory neuroepithelium cells of schizophrenia patients is modulated by cannabis use. |
2021-10-25 |
2023-08-13 |
Not clear |
| David Rentero, Francisco Arias, Sergio Sánchez-Romero, Gabriel Rubio, Roberto Rodríguez-Jiméne. Cannabis-induced psychosis: clinical characteristics and its differentiation from schizophrenia with and without cannabis use. Adicciones. vol 33. issue 2. 2021-10-25. PMID:32677690. |
cannabis-induced psychosis: clinical characteristics and its differentiation from schizophrenia with and without cannabis use. |
2021-10-25 |
2023-08-13 |
Not clear |
| David Rentero, Francisco Arias, Sergio Sánchez-Romero, Gabriel Rubio, Roberto Rodríguez-Jiméne. Cannabis-induced psychosis: clinical characteristics and its differentiation from schizophrenia with and without cannabis use. Adicciones. vol 33. issue 2. 2021-10-25. PMID:32677690. |
three inpatients groups were differentiated: cannabis-induced psychosis (cip) (n = 69; mean age = 27.4, sd = 6.5; 82.6% males), schizophrenia with cannabis abuse or dependence (sz + cb) (n = 57; mean age = 31.9, sd = 10.1; 94.7% males) and schizophrenia without cannabis abuse or dependence (sz) (n = 181; mean age = 41.8, sd = 13.3; 54.1% males). |
2021-10-25 |
2023-08-13 |
Not clear |
| Nehal P Vadhan, Mark R Serper, Margaret Hane. Effects of Δ-THC on Working Memory: Implications for Schizophrenia? Primary psychiatry. vol 16. issue 4. 2021-10-20. PMID:20351792. |
this article reviews the literature on the acute effects of delta 9-tetrahydrocannabinol, the primary psychoactive component of marijuana, on working memory, and the implications for schizophrenia. |
2021-10-20 |
2023-08-12 |
Not clear |
| Steven R Williams, James R Agapoff, Devesh Jalan, Earl S Hishinuma, Lauren E Kid. Psychiatric Hospitalization and Length of Stay Differences in Cannabis Users and Non-Users with a Primary Discharge Diagnosis of Schizophrenia or Schizoaffective Disorder. Substance use & misuse. vol 56. issue 11. 2021-10-20. PMID:34263706. |
psychiatric hospitalization and length of stay differences in cannabis users and non-users with a primary discharge diagnosis of schizophrenia or schizoaffective disorder. |
2021-10-20 |
2023-08-13 |
Not clear |
| Steven R Williams, James R Agapoff, Devesh Jalan, Earl S Hishinuma, Lauren E Kid. Psychiatric Hospitalization and Length of Stay Differences in Cannabis Users and Non-Users with a Primary Discharge Diagnosis of Schizophrenia or Schizoaffective Disorder. Substance use & misuse. vol 56. issue 11. 2021-10-20. PMID:34263706. |
the effects of cannabis use in vulnerable persons with schizophrenia or schizoaffective disorder, continues to be elucidated. |
2021-10-20 |
2023-08-13 |
Not clear |
| Kirsten Jahn, Astrid Heese, Oussama Kebir, Adrian Groh, Stefan Bleich, Marie Odile Krebs, Helge Frielin. Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls. Neuropsychobiology. vol 80. issue 1. 2021-10-18. PMID:32599581. |
therefore, we investigated whether consumption of cannabis has an impact on the methylation pattern of schizophrenia candidate genes concerned with the development and preservation of synapses and synaptic function. |
2021-10-18 |
2023-08-13 |
Not clear |
| Paul D Morrison, Robin M Murra. Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162768. |
cannabis can elicit an acute psychotic reaction, and its long-term use is a risk factor for schizophrenia. |
2021-10-11 |
2023-08-13 |
Not clear |
| Diego Quattrone, Ulrich Reininghaus, Alex L Richards, Giada Tripoli, Laura Ferraro, Andrea Quattrone, Paolo Marino, Victoria Rodriguez, Edoardo Spinazzola, Charlotte Gayer-Anderson, Hannah E Jongsma, Peter B Jones, Caterina La Cascia, Daniele La Barbera, Ilaria Tarricone, Elena Bonora, Sarah Tosato, Antonio Lasalvia, Andrei Szöke, Celso Arango, Miquel Bernardo, Julio Bobes, Cristina Marta Del Ben, Paulo Rossi Menezes, Pierre-Michel Llorca, Jose Luis Santos, Julio Sanjuán, Manuel Arrojo, Andrea Tortelli, Eva Velthorst, Steven Berendsen, Lieuwe de Haan, Bart P F Rutten, Michael T Lynskey, Tom P Freeman, James B Kirkbride, Pak C Sham, Michael C O'Donovan, Alastair G Cardno, Evangelos Vassos, Jim van Os, Craig Morgan, Robin M Murray, Cathryn M Lewis, Marta Di Fort. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational psychiatry. vol 11. issue 1. 2021-10-11. PMID:34376640. |
the continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the eu-gei study. |
2021-10-11 |
2023-08-13 |
Not clear |
| Diego Quattrone, Ulrich Reininghaus, Alex L Richards, Giada Tripoli, Laura Ferraro, Andrea Quattrone, Paolo Marino, Victoria Rodriguez, Edoardo Spinazzola, Charlotte Gayer-Anderson, Hannah E Jongsma, Peter B Jones, Caterina La Cascia, Daniele La Barbera, Ilaria Tarricone, Elena Bonora, Sarah Tosato, Antonio Lasalvia, Andrei Szöke, Celso Arango, Miquel Bernardo, Julio Bobes, Cristina Marta Del Ben, Paulo Rossi Menezes, Pierre-Michel Llorca, Jose Luis Santos, Julio Sanjuán, Manuel Arrojo, Andrea Tortelli, Eva Velthorst, Steven Berendsen, Lieuwe de Haan, Bart P F Rutten, Michael T Lynskey, Tom P Freeman, James B Kirkbride, Pak C Sham, Michael C O'Donovan, Alastair G Cardno, Evangelos Vassos, Jim van Os, Craig Morgan, Robin M Murray, Cathryn M Lewis, Marta Di Fort. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational psychiatry. vol 11. issue 1. 2021-10-11. PMID:34376640. |
using data from the eu-gei study, we evaluated the impact of schizophrenia polygenic risk score (sz-prs) and patterns of cannabis use on the transdiagnostic expression of psychosis. |
2021-10-11 |
2023-08-13 |
Not clear |
| Diego Quattrone, Ulrich Reininghaus, Alex L Richards, Giada Tripoli, Laura Ferraro, Andrea Quattrone, Paolo Marino, Victoria Rodriguez, Edoardo Spinazzola, Charlotte Gayer-Anderson, Hannah E Jongsma, Peter B Jones, Caterina La Cascia, Daniele La Barbera, Ilaria Tarricone, Elena Bonora, Sarah Tosato, Antonio Lasalvia, Andrei Szöke, Celso Arango, Miquel Bernardo, Julio Bobes, Cristina Marta Del Ben, Paulo Rossi Menezes, Pierre-Michel Llorca, Jose Luis Santos, Julio Sanjuán, Manuel Arrojo, Andrea Tortelli, Eva Velthorst, Steven Berendsen, Lieuwe de Haan, Bart P F Rutten, Michael T Lynskey, Tom P Freeman, James B Kirkbride, Pak C Sham, Michael C O'Donovan, Alastair G Cardno, Evangelos Vassos, Jim van Os, Craig Morgan, Robin M Murray, Cathryn M Lewis, Marta Di Fort. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational psychiatry. vol 11. issue 1. 2021-10-11. PMID:34376640. |
we provide evidence that genetic liability to schizophrenia and cannabis use map onto transdiagnostic symptom dimensions, supporting the validity and utility of the dimensional representation of psychosis. |
2021-10-11 |
2023-08-13 |
Not clear |
| Diego Quattrone, Ulrich Reininghaus, Alex L Richards, Giada Tripoli, Laura Ferraro, Andrea Quattrone, Paolo Marino, Victoria Rodriguez, Edoardo Spinazzola, Charlotte Gayer-Anderson, Hannah E Jongsma, Peter B Jones, Caterina La Cascia, Daniele La Barbera, Ilaria Tarricone, Elena Bonora, Sarah Tosato, Antonio Lasalvia, Andrei Szöke, Celso Arango, Miquel Bernardo, Julio Bobes, Cristina Marta Del Ben, Paulo Rossi Menezes, Pierre-Michel Llorca, Jose Luis Santos, Julio Sanjuán, Manuel Arrojo, Andrea Tortelli, Eva Velthorst, Steven Berendsen, Lieuwe de Haan, Bart P F Rutten, Michael T Lynskey, Tom P Freeman, James B Kirkbride, Pak C Sham, Michael C O'Donovan, Alastair G Cardno, Evangelos Vassos, Jim van Os, Craig Morgan, Robin M Murray, Cathryn M Lewis, Marta Di Fort. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational psychiatry. vol 11. issue 1. 2021-10-11. PMID:34376640. |
in our sample, genetic liability to schizophrenia correlated with more severe psychosis presentation, and cannabis use conferred risk to positive symptomatology beyond the genetic risk. |
2021-10-11 |
2023-08-13 |
Not clear |
| Emma C Johnson, Alexander S Hatoum, Joseph D Deak, Renato Polimanti, Robin M Murray, Howard J Edenberg, Joel Gelernter, Marta Di Forti, Arpana Agrawa. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction (Abingdon, England). vol 116. issue 11. 2021-10-08. PMID:33950550. |
the relationship between cannabis and schizophrenia: a genetically informed perspective. |
2021-10-08 |
2023-08-13 |
Not clear |
| Emma C Johnson, Alexander S Hatoum, Joseph D Deak, Renato Polimanti, Robin M Murray, Howard J Edenberg, Joel Gelernter, Marta Di Forti, Arpana Agrawa. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction (Abingdon, England). vol 116. issue 11. 2021-10-08. PMID:33950550. |
while epidemiological studies support a role for heavy, high-potency cannabis use on first-episode psychosis, genetic models of causation suggest reverse causal effects of schizophrenia on cannabis use liability. |
2021-10-08 |
2023-08-13 |
Not clear |
| Emma C Johnson, Alexander S Hatoum, Joseph D Deak, Renato Polimanti, Robin M Murray, Howard J Edenberg, Joel Gelernter, Marta Di Forti, Arpana Agrawa. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction (Abingdon, England). vol 116. issue 11. 2021-10-08. PMID:33950550. |
we estimated the genetic relationship between cannabis use disorder (cud) and schizophrenia (scz) and tested whether liability for cud is causally associated with increased liability to scz while adjusting for tobacco smoking. |
2021-10-08 |
2023-08-13 |
Not clear |
| Raghav Shah, Abhishek Ghosh, Ajit Avasthi, Ritu Nehra, Chirag K Ahuja, Niranjan Khandelwa. Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study. International journal of psychiatry in clinical practice. vol 25. issue 3. 2021-09-17. PMID:33856944. |
do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? |
2021-09-17 |
2023-08-13 |
Not clear |
| Raghav Shah, Abhishek Ghosh, Ajit Avasthi, Ritu Nehra, Chirag K Ahuja, Niranjan Khandelwa. Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study. International journal of psychiatry in clinical practice. vol 25. issue 3. 2021-09-17. PMID:33856944. |
we compared neurocognitive functions in cip, schizophrenia with cannabis use (szc) and healthy control group (cg). |
2021-09-17 |
2023-08-13 |
Not clear |